Inhalt

Team

Prof. Dr. med. Daniel Nowak

Head of Research Laboratory
Head of Molecular Tumor Board
Endowed Professor of the German José-Carreras-Foundation

Dr. sc. hum. Eva Altrock

M. sc. Nanni Schmitt

Generation of MDS models to be used as pre-clinical platforms, and their further optimization
Pre-clinical assessment of NK cell based therapies for treatment of AML and high-risk MDS
(PhD student: Alexandra Beck)

Dr. sc. hum. Vladimir Riabov

Dr. med. Qingyu Xu

Phone +49 621/383-71310

Role of MSC/HSC crosstalk in the pathogenesis of myeloid neoplasms (MDS and MPN), molecular studies (Vladimir Riabov and Qingyu Xu)
Generation of preclinical models to therapeutically target AML/immune cell crosstalk (Vladimir Riabov)
R-loops mediated replication stress as a novel therapeutic target in MDS with splicing factor mutations (Vladimir Riabov and MD student: Marie Demmerle)
Investigation of the role of BM microenvironment in MDS (Vladimir Riabov and Qingyu Xu)

Phone +49 621/383-71310

Role of MSC/HSC crosstalk in the pathogenesis of myeloid neoplasms (MDS and MPN), molecular studies (Vladimir Riabov and Qingyu Xu)
Generation of preclinical models to therapeutically target AML/immune cell crosstalk (Vladimir Riabov)
R-loops mediated replication stress as a novel therapeutic target in MDS with splicing factor mutations (Vladimir Riabov and MD student: Marie Demmerle)
Investigation of the role of BM microenvironment in MDS (Vladimir Riabov and Qingyu Xu)

Dr. med. Alexander Streuer

Phone +49 621/383-71314 or -4115

Next Generation Sequencing (RNA sequencing, whole exome sequencing, single-cell RNA sequencing)
Pipelines for the analysis of clonal alterations of leukemic cells
“Radiomics”- the role of spatial sampling for Contact: therapy decisions and outcome